Abstract
The term indeterminate colitis was first introduced in the 1970s to further classify a subset of patients with inflammatory bowel disease, whose surgical colectomy specimens showed features consistent with both ulcerative colitis and Crohn disease. With time, advances in diagnostics, and recognition of diverse phenotypes of disease, this definition has evolved. In this chapter, we will review the criteria used to establish a diagnosis of inflammatory bowel disease-unclassified (IBD-U), the epidemiology of IBD-U, diagnostic evaluation, as well as considerations for medical and surgical management.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- CD:
-
Crohn Disease
- UC:
-
Ulcerative Colitis
- IBD:
-
Inflammatory Bowel Disease
- IBD-U:
-
Inflammatory Bowel Disease-Unclassified
References
Price AB. Overlap in the spectrum of non-specific inflammatory bowel disease—‘colitis indeterminate’. J Clin Pathol. 1978;31:567–77.
Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749–53.
Levine A, Griffiths A, Markowitz J, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis. 2011;17:1314–21.
North American Society for Pediatric Gastroenterology H, Nutrition, Colitis Foundation of A, et al. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn’s and Colitis Foundation of America. J Pediatr Gastroenterol Nutr. 2007;44:653–74.
Levine A, Koletzko S, Turner D, et al. ESPGHAN revised Porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr. 2014;58:795–806.
Birimberg-Schwartz L, Zucker DM, Akriv A, et al. Development and validation of diagnostic criteria for IBD subtypes including IBD-unclassified in children: a multicentre study from the pediatric IBD Porto Group of ESPGHAN. J Crohns Colitis. 2017;11:1078–84.
Benchimol EI, Guttmann A, Griffiths AM, et al. Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data. Gut. 2009;58:1490–7.
Chan JM, Carroll MW, Smyth M, et al. Comparing health administrative and clinical registry data: trends in incidence and prevalence of pediatric inflammatory bowel disease in British Columbia. Clin Epidemiol. 2021;13:81–90.
Jabandziev P, Pinkasova T, Kunovsky L, et al. Regional incidence of inflammatory bowel disease in a Czech pediatric population: 16 years of experience (2002–2017). J Pediatr Gastroenterol Nutr. 2020;70:586–92.
Sykora J, Pomahacova R, Kreslova M, et al. Current global trends in the incidence of pediatric-onset inflammatory bowel disease. World J Gastroenterol. 2018;24:2741–63.
Adamiak T, Walkiewicz-Jedrzejczak D, Fish D, et al. Incidence, clinical characteristics, and natural history of pediatric IBD in Wisconsin: a population-based epidemiological study. Inflamm Bowel Dis. 2013;19:1218–23.
Benchimol EI, Manuel DG, Guttmann A, et al. Changing age demographics of inflammatory bowel disease in Ontario, Canada: a population-based cohort study of epidemiology trends. Inflamm Bowel Dis. 2014;20:1761–9.
Muller KE, Lakatos PL, Arato A, et al. Incidence, Paris classification, and follow-up in a nationwide incident cohort of pediatric patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2013;57:576–82.
Abramson O, Durant M, Mow W, et al. Incidence, prevalence, and time trends of pediatric inflammatory bowel disease in Northern California, 1996 to 2006. J Pediatr. 2010;157:233–9. e1
Pinsk V, Lemberg DA, Grewal K, et al. Inflammatory bowel disease in the South Asian pediatric population of British Columbia. Am J Gastroenterol. 2007;102:1077–83.
van der Zaag-Loonen HJ, Casparie M, Taminiau JA, et al. The incidence of pediatric inflammatory bowel disease in the Netherlands: 1999–2001. J Pediatr Gastroenterol Nutr. 2004;38:302–7.
Chandradevan R, Hofmekler T, Mondal K, et al. Evolution of pediatric inflammatory bowel disease unclassified (IBD-U): incorporated with serological and gene expression profiles. Inflamm Bowel Dis. 2018;24:2285–90.
Dhaliwal J, Walters TD, Mack DR, et al. Phenotypic variation in paediatric inflammatory bowel disease by age: a multicentre prospective inception cohort study of the canadian children IBD network. J Crohns Colitis. 2020;14:445–54.
Malaty HM, Mehta S, Abraham B, et al. The natural course of inflammatory bowel disease-indeterminate from childhood to adulthood: within a 25 year period. Clin Exp Gastroenterol. 2013;6:115–21.
Prenzel F, Uhlig HH. Frequency of indeterminate colitis in children and adults with IBD – a metaanalysis. J Crohns Colitis. 2009;3:277–81.
Everhov AH, Sachs MC, Malmborg P, et al. Changes in inflammatory bowel disease subtype during follow-up and over time in 44,302 patients. Scand J Gastroenterol. 2019;54:55–63.
Heyman MB, Kirschner BS, Gold BD, et al. Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. J Pediatr. 2005;146:35–40.
Winter DA, Karolewska-Bochenek K, Lazowska-Przeorek I, et al. Pediatric IBD-unclassified is less common than previously reported; results of an 8-year audit of the EUROKIDS registry. Inflamm Bowel Dis. 2015;21:2145–53.
Aziz DA, Moin M, Majeed A, et al. Paediatric inflammatory bowel disease: clinical presentation and disease location. Pak J Med Sci. 2017;33:793–7.
Buderus S, Scholz D, Behrens R, et al. Inflammatory bowel disease in pediatric patients: characteristics of newly diagnosed patients from the CEDATA-GPGE Registry. Dtsch Arztebl Int. 2015;112:121–7.
Rinawi F, Assa A, Eliakim R, et al. The natural history of pediatric-onset IBD-unclassified and prediction of Crohn’s disease reclassification: a 27-year study. Scand J Gastroenterol. 2017;52:558–63.
Ashton JJ, Bonduelle Q, Mossotto E, et al. Endoscopic and histological assessment of paediatric inflammatory bowel disease over a 3-year follow-up period. J Pediatr Gastroenterol Nutr. 2018;66:402–9.
Maltz R, Podberesky DJ, Saeed SA. Imaging modalities in pediatric inflammatory bowel disease. Curr Opin Pediatr. 2014;26:590–6.
Quencer KB, Nimkin K, Mino-Kenudson M, et al. Detecting active inflammation and fibrosis in pediatric Crohn’s disease: prospective evaluation of MR-E and CT-E. Abdom Imaging. 2013;38:705–13.
Anupindi SA, Grossman AB, Nimkin K, et al. Imaging in the evaluation of the young patient with inflammatory bowel disease: what the gastroenterologist needs to know. J Pediatr Gastroenterol Nutr. 2014;59:429–39.
Schooler GR, Hull NC, Mavis A, et al. MR imaging evaluation of inflammatory bowel disease in children: where are we now in 2019. Magn Reson Imaging Clin N Am. 2019;27:291–300.
Gokli A, Dillman JR, Humphries PD, et al. Contrast-enhanced ultrasound of the pediatric bowel. Pediatr Radiol. 2021;51:2214–28.
Ripolles T, Martinez-Perez MJ, Paredes JM, et al. Contrast-enhanced ultrasound in the differentiation between phlegmon and abscess in Crohn’s disease and other abdominal conditions. Eur J Radiol. 2013;82:e525–31.
de Bie CI, Buderus S, Sandhu BK, et al. Diagnostic workup of paediatric patients with inflammatory bowel disease in Europe: results of a 5-year audit of the EUROKIDS registry. J Pediatr Gastroenterol Nutr. 2012;54:374–80.
Netz U, Galbraith NJ, O'Brien S, et al. Long-term outcomes following ileal pouch-anal anastomosis in patients with indeterminate colitis. Surgery. 2018;163:535–41.
Min SB, Le-Carlson M, Singh N, et al. Video capsule endoscopy impacts decision making in pediatric IBD: a single tertiary care center experience. Inflamm Bowel Dis. 2013;19:2139–45.
Monteiro S, Dias de Castro F, Boal Carvalho P, et al. Essential role of small bowel capsule endoscopy in reclassification of colonic inflammatory bowel disease type unclassified. World J Gastrointest Endosc. 2017;9:34–40.
Aloi M, Birimberg-Schwartz L, Buderus S, et al. Treatment options and outcomes of pediatric IBDU compared with other IBD subtypes: a retrospective multicenter study from the IBD Porto Group of ESPGHAN. Inflamm Bowel Dis. 2016;22:1378–83.
Maxwell EC, Dawany N, Baldassano RN, et al. Diverting ileostomy for the treatment of severe, refractory, pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2017;65:299–305.
Yu CS, Pemberton JH, Larson D. Ileal pouch-anal anastomosis in patients with indeterminate colitis: long-term results. Dis Colon Rectum. 2000;43:1487–96.
Jackson KL, Stocchi L, Duraes L, et al. Long-term outcomes in indeterminate colitis patients undergoing ileal pouch-anal anastomosis: function, quality of life, and complications. J Gastrointest Surg. 2017;21:56–61.
Turina M, Remzi FH. The J-pouch for patients with Crohn’s disease and indeterminate colitis: (when) is it an option? J Gastrointest Surg. 2014;18:1343–4.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Boyer, B., Mitchel, E.B. (2023). Pediatric Inflammatory Bowel Disease: Unclassified. In: Mamula, P., Kelsen, J.R., Grossman, A.B., Baldassano, R.N., Markowitz, J.E. (eds) Pediatric Inflammatory Bowel Disease. Springer, Cham. https://doi.org/10.1007/978-3-031-14744-9_9
Download citation
DOI: https://doi.org/10.1007/978-3-031-14744-9_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-14743-2
Online ISBN: 978-3-031-14744-9
eBook Packages: MedicineMedicine (R0)